BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23827758)

  • 21. Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
    Chang KC; Li L; Sanborn TM; Shieh B; Lenhart P; Ammar D; LaBarbera DV; Petrash JM
    J Nat Prod; 2016 May; 79(5):1439-44. PubMed ID: 27140653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
    Griffin BW; McNatt LG; Chandler ML; York BM
    Metabolism; 1987 May; 36(5):486-90. PubMed ID: 3106757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB; Fukui H
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats.
    Saraswat M; Suryanarayana P; Reddy PY; Patil MA; Balakrishna N; Reddy GB
    Mol Vis; 2010 Aug; 16():1525-37. PubMed ID: 20806076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.
    Ahmad SS; Tsou KC; Ahmad SI; Rahman MA
    Ophthalmic Res; 1985; 17(1):12-20. PubMed ID: 2984623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of Alrestatin, an aldose reductase inhibitor, in human diabetic and nondiabetic lenses.
    Chylack LT; Henriques HF; Cheng HM; Tung WH
    Ophthalmology; 1979 Sep; 86(9):1579-85. PubMed ID: 121768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactive fraction of Saraca indica prevents diabetes induced cataractogenesis: An aldose reductase inhibitory activity.
    Somani G; Sathaye S
    Pharmacogn Mag; 2015; 11(41):102-10. PubMed ID: 25709218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitigation of lens opacification by a functional food in a diabetic rodent model.
    Kalahasti KK; Kumar CU; Nagaraju M; Petrash JM; Reddy SS; Reddy GB
    Chem Biol Interact; 2024 Feb; 390():110889. PubMed ID: 38272248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary myo-inositol effect on sugar cataractogenesis.
    Beyer-Mears A; Bucci FA; Del Val M; Cruz E
    Pharmacology; 1989; 39(1):59-68. PubMed ID: 2587618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataract.
    Wu J; Li X; Fang H; Yi Y; Chen D; Long Y; Gao X; Wei X; Chen CY
    BMC Complement Altern Med; 2016 Aug; 16(1):286. PubMed ID: 27520089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
    Ohrloff C; Hockwin O; Korte I; Wegener A
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aldose reductase inhibitors and cataract.
    Crabbe MJ
    Int Ophthalmol; 1991 Jan; 15(1):25-36. PubMed ID: 1901300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats.
    Thiraphatthanavong P; Wattanathorn J; Muchimapura S; Thukham-mee W; Lertrat K; Suriharn B
    Oxid Med Cell Longev; 2014; 2014():789406. PubMed ID: 25614778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phytochemical evaluation, antimicrobial activity, and determination of bioactive components from leaves of Aegle marmelos.
    Mujeeb F; Bajpai P; Pathak N
    Biomed Res Int; 2014; 2014():497606. PubMed ID: 24900969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
    Xu GT; Zigler JS; Lou MF
    Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitative study of rat diabetic cataract, by the relaxation times of nuclear magnetic resonance].
    Mori K; Terubayashi H; Akagi Y; Okamoto S; Tsutsumi M; Ikebe H; Yoshizaki K; Nishikawa H
    Nippon Ganka Gakkai Zasshi; 1991 Apr; 95(4):336-42. PubMed ID: 1908617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of lens aldose reductase by flavonoids--their possible role in the prevention of diabetic cataracts.
    Varma SD; Kinoshita JH
    Biochem Pharmacol; 1976 Nov; 25(22):2505-13. PubMed ID: 825129
    [No Abstract]   [Full Text] [Related]  

  • 38. [The localization of aldose reductase mRNA in the rat lens].
    Okamoto S; Terubayashi H; Tsutsumi M; Ikebe H; Akagi Y; Nishimura C; Kador PF
    Nippon Ganka Gakkai Zasshi; 1992 Nov; 96(11):1373-8. PubMed ID: 1476067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confirmation of lens hydration by Raman spectroscopy.
    Mizuno A; Toshima S; Mori Y
    Exp Eye Res; 1990 Jun; 50(6):647-9. PubMed ID: 2115454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of rat lens aldose reductase by bendazac-L-lysine salt.
    Iuliano G; Menzione M; Apponi-Battini G; Costagliola C
    Enzyme; 1989; 42(4):235-7. PubMed ID: 2517113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.